These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10888985)

  • 1. The need for improving information systems on drug interactions in Japan.
    Harada K; Fujimura A
    Arch Intern Med; 2000 Jul; 160(13):2063-4. PubMed ID: 10888985
    [No Abstract]   [Full Text] [Related]  

  • 2. Strategic proposals for predicting drug-drug interactions during new drug development: based on sixteen deaths caused by interactions of the new antiviral sorivudine with 5-fluorouracil prodrugs.
    Watabe T
    J Toxicol Sci; 1996 Dec; 21(5):299-300. PubMed ID: 9035040
    [No Abstract]   [Full Text] [Related]  

  • 3. An open letter to the FDA regarding changes in reporting procedures for drugs and biologics proposed in the wake of the FIAU tragedy.
    Meinert CL
    Control Clin Trials; 1996 Aug; 17(4):273-84. PubMed ID: 8889342
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of sorivudine-related agranulocytosis with granulocyte-colony stimulating factor.
    Sato H; Oh H; Cho R; Nakamura H; Asai T
    Am J Hematol; 1995 Nov; 50(3):227. PubMed ID: 7485091
    [No Abstract]   [Full Text] [Related]  

  • 5. Mitochondrial toxicity--new adverse drug effects.
    Swartz MN
    N Engl J Med; 1995 Oct; 333(17):1146-8. PubMed ID: 7565955
    [No Abstract]   [Full Text] [Related]  

  • 6. Concern grows over reaction to deaths in clinical trials.
    Macilwain C
    Nature; 1994 May; 369(6478):268. PubMed ID: 8183354
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention of drug interactions and its countermeasure].
    Nakamura H; Omori S; Kitada K; Mochida A
    J Toxicol Sci; 1994 Aug; 19(3):App89-93. PubMed ID: 7966447
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lethal interaction between 5-fluorouracil and brivudine].
    García Herrera AN; Moncayola Vicén JC
    An Sist Sanit Navar; 2018 Aug; 41(2):277-278. PubMed ID: 29943764
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe toxicity of fialuridine (FIAU).
    Josephson L
    N Engl J Med; 1996 Apr; 334(17):1135-6; author reply 1137-8. PubMed ID: 8598880
    [No Abstract]   [Full Text] [Related]  

  • 10. NIH, FDA seek lessons from hepatitis B drug trial deaths.
    Macilwain C
    Nature; 1993 Jul; 364(6435):275. PubMed ID: 8332178
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe toxicity of fialuridine (FIAU).
    Lewis W; Perrino FW
    N Engl J Med; 1996 Apr; 334(17):1136; author reply 1137-8. PubMed ID: 8598881
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe toxicity of fialuridine (FIAU).
    Prince AM
    N Engl J Med; 1996 Apr; 334(17):1136; author reply 1137-8. PubMed ID: 8598882
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacovigilance as new direction of research].
    Gaszner G; Makkos Z; Gaszner P
    Neuropsychopharmacol Hung; 2005 Dec; 7(4):194-8. PubMed ID: 16496484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal relationship between multiple drugs and multiple events in patient reports on adverse drug reactions: findings in a pilot study in Japan.
    Kubota K; Okazaki M; Dobashi A; Yamamoto M; Hashiguchi M; Horie A; Inagaki A; Kikuchi T; Mochizuki M
    Pharmacoepidemiol Drug Saf; 2013 Oct; 22(10):1134-7. PubMed ID: 24092565
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe toxicity of fialuridine (FIAU).
    Gordon M
    N Engl J Med; 1996 Apr; 334(17):1136-7; author reply 1137-8. PubMed ID: 8598883
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenytoin toxicity as a result of 5-fluorouracil administration.
    Rosemergy I; Findlay M
    N Z Med J; 2002 Aug; 115(1159):U124. PubMed ID: 12362168
    [No Abstract]   [Full Text] [Related]  

  • 17. Improving drug safety monitoring.
    Karande S; Gogtay NJ; Kshirsagar NA
    Indian Pediatr; 2003 Dec; 40(12):1167-75. PubMed ID: 14722367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keeping your patient with heart failure safe: a review of potentially dangerous medications.
    Amabile CM; Spencer AP
    Arch Intern Med; 2004 Apr; 164(7):709-20. PubMed ID: 15078640
    [No Abstract]   [Full Text] [Related]  

  • 19. Trial deaths prompt tighter rules.
    Macilwain C
    Nature; 1993 Nov; 366(6453):294. PubMed ID: 8247116
    [No Abstract]   [Full Text] [Related]  

  • 20. Providing patients with written information helps them to be aware of and report adverse drug reactions?
    Harada K; Yamazaki S; Fujimura A
    Br J Clin Pharmacol; 1999 Feb; 47(2):228-9. PubMed ID: 10190663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.